Cargando…

Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China

BACKGROUND: Follicular lymphoma (FL) is characterized by an incurable course that frequently necessitates multiple lines of treatment. While a range of new approaches have broadened therapeutic options for patients in later lines, data regarding treatment patterns and outcomes of Chinese patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jiaxin, Hu, Yunfei, Zhao, Linjun, Nuersulitan, Reyizha, Liu, Yanfei, Yu, Hui, Ye, Yingying, Wang, Dedao, Tang, Yongjing, Feng, Feier, Liu, Weiping, Zhu, Jun, Ping, Lingyan, Song, Yuqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628462/ https://www.ncbi.nlm.nih.gov/pubmed/37941553 http://dx.doi.org/10.3389/fonc.2023.1264723

Ejemplares similares

Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era
por: Nuersulitan, Reyizha, et al.
Publicado: (2022)

Conditional Survival and Annual Hazard Estimates of Classical Hodgkin Lymphoma
por: Nuersulitan, Reyizha, et al.
Publicado: (2021)

A Prospective Phase II Study of Pegaspargase-COEP Plus Radiotherapy in Patients With Newly Diagnosed Extra-Nodal NK/T-Cell Lymphoma
por: Hu, Shaoxuan, et al.
Publicado: (2022)

Mortality Rate of Lymphoma in China, 2013–2020
por: Liu, Weiping, et al.
Publicado: (2022)

Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)

P1287: HETROMBOPAG FOR ENHANCEMENT OF PLATELET ENGRAFTMENT IN PATIENTS WITH LYMPHOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Zhao, Linjun, et al.
Publicado: (2023)

Cancer Immunotherapy and the Immune Response in Follicular Lymphoma
por: Stenner, Frank, et al.
Publicado: (2018)

A rare case of follicular lymphoma of the bladder
por: DeSanto, Matthew, et al.
Publicado: (2023)

Treatment selection for patients with relapsed or refractory follicular lymphoma
por: Skarbnik, Alan Z., et al.
Publicado: (2023)

Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular Lymphoma
por: Takada, Ryutaro, et al.
Publicado: (2021)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021)

Pathologic and molecular insights in nodal T-follicular helper cell lymphomas
por: Marques-Piubelli, Mario L., et al.
Publicado: (2023)

Mutational patterns along different evolution paths of follicular lymphoma
por: Michaeli, Miri, et al.
Publicado: (2022)

Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study
por: Liu, Shuo, et al.
Publicado: (2022)

The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma
por: Wang, Xing, et al.
Publicado: (2021)

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China
por: Gao, Fenghua, et al.
Publicado: (2022)

Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas
por: Ye, Yingying, et al.
Publicado: (2021)

Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
por: Huntington, Scott F., et al.
Publicado: (2022)

Angioimmunoblastic T-cell lymphoma with extensive follicular dendritic cell and fibroblastic reticular cell network proliferation mimicking follicular dendritic cell sarcoma: A case report with pathologic, immunophenotypic, and molecular findings
por: Zhang, Fen, et al.
Publicado: (2022)

The Status and Prospects of Epigenetics in the Treatment of Lymphoma
por: Liu, Jiaxin, et al.
Publicado: (2022)

Follicular Dendritic Cell Sarcoma With Co-Expression of CD4 and CD30 Mimics Anaplastic Large Cell Lymphoma
por: Liu, Hui, et al.
Publicado: (2020)

Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
por: Claustre, Gwladys, et al.
Publicado: (2022)

Treatment Patterns and Health Care Costs in Commercially Insured Patients with Follicular Lymphoma
por: Fowler, Nathan H., et al.
Publicado: (2020)

Precise diagnosis and targeted therapy of nodal T-follicular helper cell lymphoma (T-FHCL)
por: Du, Jun, et al.
Publicado: (2023)

Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
por: Rivero, Andrea, et al.
Publicado: (2023)

Effect of autologous hematopoietic stem cell transplantation for patients with peripheral T-cell lymphoma in China: A propensity score-matched analysis
por: Gao, Hongye, et al.
Publicado: (2022)

A rare face of follicular lymphoma: reverse variant of follicular lymphoma
por: Maskey, Ninu, et al.
Publicado: (2020)

Primary follicular lymphoma of the bladder mimicking inflammatory condition: Case report and review of the literature
por: Haghi, Nina, et al.
Publicado: (2019)

Primary follicular lymphoma of an extraordinarily large prostate: A case report and review of the literature
por: Williams, Isabella S.C., et al.
Publicado: (2023)

Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022)

Secondary Cutaneous Involvement in Follicular Diffuse Lymphoma Treated with Helical Tomotherapy
por: Dar, A. Rashid, et al.
Publicado: (2017)

Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II study
por: Liu, Yanfei, et al.
Publicado: (2023)

Disparities in Receipt of Radiotherapy and Survival by Age, Sex, and Ethnicity among Patient with Stage I Follicular Lymphoma
por: Bista, Amir, et al.
Publicado: (2016)

Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma
por: So, Heejune, et al.
Publicado: (2023)

Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy
por: Li, Miaomiao, et al.
Publicado: (2022)

Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma
por: Yu, Hui, et al.
Publicado: (2021)

Development and validation of a population-based prognostic nomogram for primary colorectal lymphoma patients
por: Chen, Qian, et al.
Publicado: (2022)

Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis
por: Lu, Xiaoxuan, et al.
Publicado: (2022)

Case Report: Primary NK/T Cell Lymphoma Nasal Type of the Colon With Multiple Intestinal Perforations
por: Zhang, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_05n3dk7rci8um65ld46iotu51t